中华神经科杂志
2015年 · 第48卷第11期
中华神经科杂志
myopath with rimmed vacuoles refers to a myopathy manifested by the pathologically observed presence of a special vacuoles in the muscle fibers. With the popularization and application of muscle pathological diagnosis technology, peers in neuromuscular diseases have gradually discovered that edge vacuoles are a non-specific muscle tissue pathological change, which can appear in many kinds of muscles; However, sometimes, patients have undergone comprehensive testing of related genes, but still can't find the mutation, can't determine the type, and can only use the diagnosis of "marginal vacuolar myopathy".
myasthenia gravis (MG) is an acquired autoimmune disease mediated by acetylcholine receptor (AChR) antibody, cellular immune-dependent, complement-involved, involving the postsynaptic membrane of the neuromuscular junction, causing neuromuscular junction transmission disorder and skeletal muscle contraction weakness. A very small proportion of MG patients are mediated by muscle specific tyrosine kinase (MuSK) antibodies and low-density lipoprotein receptor-related protein 4 (LRP4) antibodies. Its main clinical manifestations are skeletal muscle weakness, easy fatigue, aggravation after activity, and obvious relief and reduction of symptoms after rest and application of cholinesterase inhibitors. The average annual incidence rate is (8.0-20.0) /100,000 people[
lipid storage myopathy (LSM) refers to a group of myopathies with fat deposition in muscle fibers as the main pathological feature caused by enzyme or prosthetic group defects in the primary fat metabolism pathway. The clinical manifestations are progressive muscle weakness and exercise intolerance, and the course of the disease can be fluctuating. Two cases of LSM were first reported in China in the early 1980s[
polymyositis (PM) is an acquired muscle disease with proximal muscle involvement as the main manifestation. It belongs to idiopathic inflammatory myopathies (IIMs) along with dermatomyositis, sporadic inclusion body myositis (sIBM) and immune-mediated necrotizing myopathy (IMNM)[
Electromyography is a technique for recording various electrical properties of muscles at rest, voluntary contraction and stimulation of peripheral nerves[
Patients with coma after cardiopulmonary resuscitation may have a poor prognosis [Cerebral Performance Categories Score (CPCS) Score 3 to 5][
idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a state of increased intracranial pressure without obvious pathological basis and evidence of venous thrombosis. Clinically, the symptoms of hypertension such as headache, nausea, vomiting and papilledema are the main symptoms. IIH is common in overweight women, whose increased intracranial pressure is inferred to be related to endocrine-mediated electrolyte disorders[
brucellosis is a common zoonotic disease, most common in the Middle East, Mediterranean and South America. In China, it is more common in pastoral areas such as Inner Mongolia, Northeast China and Northwest China. In recent years, the incidence of this disease has been increasing year by year, especially in Inner Mongolia Autonomous Region, Northeast China and Xinjiang Uygur Autonomous Region. The main clinical manifestations of this disease are fever, hyperhidrosis, joint pain, hepatosplenomegaly, etc., which mostly involve joints and spine, and neurological lesions are rare. The disease has a high disability rate and a poor prognosis[
Hereditary stress-predisposed neuropathy (HNPP) is a rare autosomal dominant peripheral neuropathy, which often involves the common peroneal nerve, radial nerve and ulnar nerve, and the cranial nerve is less involved[
While Chinese clinicians are still wondering about the significance of brain injury assessment, the progress of brain injury assessment technology worldwide has spanned half a century. In 1962, Dr. Alexander evaluated intracranial hypertension in patients with craniocerebral trauma using pupil diameter and pupil-to-light reflex[
Parkinson's disease is a common neurodegenerative disease, with a prevalence of about 1.7% in the elderly population over 65 years old[
The patient was a 56-year-old male who smoked and drank alcohol for a long time. He was admitted to hospital on January 6, 2015 due to dizziness with nausea and vomiting for more than half a day. Five months ago, the patient remained dysarthria and right hemiparesis due to brainstem infarction, and hypertension and diabetes were found at the same time. Inability to speak and progressive aggravation of quadriplegia occurred after admission. Physical examination: clear consciousness, inability to speak, dysphagia, abduction of both eyeballs not reaching the edge (exposure about 2 mm), bilateral soft palate arch drooping, restricted uplift, pharyngeal reflex disappearing, tongue extension inability, right upper limb muscle strength grade IV, right lower limb muscle strength grade II, left upper and lower limb muscle strength grade II, low muscle tone of limbs, co-taxic movement and sensory examination cannot be completed, bilateral Babinsky sign positive. Auxiliary examination: Except for fasting glucose 7.60 mmol/L (↑) and fibrinogen 6.85 g/L (↑), other biochemical indexes were normal, and the routine examination of infection immunity, complete set of thyroid function, complete set of rheumatism, anti-nuclear antibody + anti-extractable nuclear antigen antibody were all normal. Cervical vascular ultrasound showed bilateral common carotid artery atherosclerosis with left common carotid artery plaque formation and bilateral internal carotid artery occlusion; Cranial MRI showed bilateral parapontine median baso-tegmental infarction in the acute phase (
myotonic dystrophy (DM) belongs to a class of neurodegenerative genetic diseases caused by abnormal amplification of unstable microsatellite DNA. Different from genetic diseases usually caused by loss or gain of protein function caused by gene mutation, DM is mainly caused by gain of RNA function. We review recent important findings regarding gain in RNA function in the pathogenesis of DM and possible potential therapeutic approaches.
malformation of cortical development (MCD) is caused by the mutation or abnormality of a certain gene or protein involved in the development of the cerebral cortex by genetic factors and external harmful factors. The most common clinical manifestation is epilepsy or mental retardation. Pathology includes cortical dysplasia, giant neurons, abnormal neurons, balloon-like cells, glial cell proliferation, ectopic nodules, etc. Different types of diseases have different pathological manifestations. At present, the treatment is mainly symptomatic treatment such as anti-epilepsy, while the clinical treatment effect of refractory epilepsy caused by MCD is not ideal, so the status of targeted therapy is becoming more and more important in the treatment. The mammalian target of rapamycin (mTOR) signaling pathway is at the center of growth and development regulation, and has attracted much attention from scholars. In the central nervous system, mTOR not only participates in cell growth, proliferation and differentiation by regulating protein synthesis and cell progression, but also is related to the development of neurons, glial proliferation, synaptic plasticity, ion channels, neurotransmitters, oxidative stress, apoptosis and autophagy. Recent studies have found that there is activation of mTOR signaling pathway in focal cortical dysplasia (FCD), tuberous sclerosis complex (TSC), hemimegalencephaly (HME), gangioglioma (GG) and other diseases[
Parkinson's disease is the second most common neurodegenerative disease. Its main pathological mechanism is the progressive degeneration and necrosis of dopaminergic neurons in substantia nigra and the formation of Lewy bodies, resulting in dopamine production disorders and a series of motor-related symptoms. At present, there is no reliable treatment method that can inhibit or even reduce the progression of Parkinson's disease. Therefore, it is of great significance to make animal models related to Parkinson's disease to understand the pathological mechanism of the disease and explore new treatment strategies.
hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, was first reported by Strumpell (1880) and Lorrain (1898) in the 19th century. It is a group of rare neurological diseases with high clinical and genetic heterogeneity[
The 7th Pan-Asian Conference on Treatment and Research of Multiple Sclerosis (PACTRIMS) was held in Taipei, Taiwan, China on November 6 – 8, 2014. Prof. Takahiko Kuta of Japan and Prof. William Bill Carroll of Australia served as the chairman and vice-chairman of the conference, respectively. Professors such as Cai Qingbiao, Akio Suzumura and Junichi Kira participated in the conference. More than 400 experts from 25 countries and regions in the Asia-Pacific region attended the conference, and well-known neurologists from Europe and America were also invited. The conference mainly involves basic and clinical research on the epidemiology, etiology, pathology, clinical manifestations, imaging and treatment of neuroimmune demyelinating diseases such as multiple sclerosis (MS), neuromyelitis optica (NMO) and neuromyelitis optica spectrum disease (NMOSD).
本期目次

